PRESS RELEASE published on 02/19/2024 at 20:20, 9 months 1 day ago STEICO: Preliminary business figures for 2023: Sales decline by 17.9% to € 365.3 million (e), EBIT ratio at 8.4% (e). Stable development expected for 2024 STEICO SE's preliminary business figures for 2023 show a 17.9% sales decline to €365.3 million. EBIT ratio is at 8.4%. Stable development expected for 2024 amid improving demand for ecological construction products Business Figures Sales Decline STEICO SE EBIT Ratio Ecological Construction Products
PRESS RELEASE published on 02/13/2024 at 12:30, 9 months 8 days ago New appointment of members of the Administrative Board of STEICO SE. STEICO SE appoints Mr Paul O'Gorman and Mrs Aiveen Kearney as members of the Administrative Board. New appointments follow Kingspan Holding GmbH's acquisition of 51.0% of STEICO shares Acquisition New Appointments STEICO SE Administrative Board Kingspan Holding GmbH
PRESS RELEASE published on 10/18/2023 at 21:30, 1 year 1 month ago STEICO SE: Demand stabilizes in third quarter
PRESS RELEASE published on 07/24/2023 at 20:17, 1 year 3 months ago STEICO SE: Slow first half with recovery at the end of the second quarter.
PRESS RELEASE published on 07/17/2023 at 20:33, 1 year 4 months ago EQS-Adhoc: STEICO SE: Sale of the majority shares in STEICO SE
PRESS RELEASE published on 06/21/2023 at 12:56, 1 year 5 months ago EQS-Adhoc: Update of the sales and earnings forecast for 2023
PRESS RELEASE published on 05/14/2023 at 14:15, 1 year 6 months ago STEICO SE: Year starts with continued stock reductions at STEICO re-sellers
PRESS RELEASE published on 05/12/2023 at 16:52, 1 year 6 months ago EQS-Adhoc: STEICO SE: Statement on current media reports
PRESS RELEASE published on 03/01/2023 at 15:29, 1 year 8 months ago EQS-Adhoc: STEICO Group affected by cyber attack
PRESS RELEASE published on 02/07/2023 at 20:10, 1 year 9 months ago STEICO SE: Preliminary figures: Revenues up by 14.7% to €445.3 million (e). Total operating revenue up by 18.2% to €467.6 million (e). EBIT totals around €63.8 million (e), EBIT margin at 13.7% (e)
Published on 11/21/2024 at 13:00, 33 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 33 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 33 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 33 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 33 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 58 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 18 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 35 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 13 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 48 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 48 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo